Representative micrographs of CD8, CD4, KLK2, and pan-cytokeratin immunostaining of tumor samples collected at day 50 (end of study) from the null × CD3 and KLK2 × CD3 15 mg/kg treatment groups are shown. Here, KLK2 is linked to neoplasm.